{"id":"W4283705836","doi":"10.1042/cs20220212","title":"The non-steroidal mineralocorticoid receptor antagonist finerenone is a novel therapeutic option for patients with Type 2 diabetes and chronic kidney disease","year":2022,"lang":"en","type":"review","venue":"Clinical Science","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Agence Nationale de la Recherche","keywords":"Medicine; Mineralocorticoid receptor; Kidney disease; Internal medicine; Diabetes mellitus; Type 2 diabetes; Atrial fibrillation; Heart failure; Clinical trial; Intensive care medicine; Cardiology; Endocrinology; Aldosterone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007014264,0.0002184541,0.0007067648,0.00005988057,0.0005322674,0.00008735654,0.0002311279,0.00008047072,0.00007094049],"category_scores_gemma":[0.0009371165,0.0001097417,0.0001802432,0.0004457645,0.000864365,0.00007502974,0.0001228474,0.000263767,0.0000119121],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001485228,"about_ca_system_score_gemma":0.001736425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001505663,"about_ca_topic_score_gemma":7.762317e-7,"domain_scores_codex":[0.9980041,0.0000448599,0.0005499735,0.0005652613,0.0005129548,0.0003227847],"domain_scores_gemma":[0.9980394,0.0005507632,0.0002869511,0.0003842315,0.0002021274,0.0005365208],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001840328,0.0002844697,0.001144283,0.000804699,0.0000521039,7.390972e-7,0.000007912868,1.602254e-7,0.0000315137,0.00004381327,0.0006959098,0.9967504],"study_design_scores_gemma":[0.001099838,0.001508756,0.009236419,0.001098273,0.0005314481,0.000001645841,0.000002471613,0.001090167,4.680273e-7,0.000007952508,0.9852576,0.0001650026],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01637923,0.9778241,0.0000566511,0.00160377,0.0008917187,0.00299952,0.0001734651,0.00003125646,0.00004027542],"genre_scores_gemma":[0.002980023,0.9943394,0.0002392234,0.001076066,0.0002908872,0.00014252,0.0002788082,0.00003029915,0.0006227618],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9965854,"threshold_uncertainty_score":0.4475136,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0818879306056589,"score_gpt":0.3800843912460095,"score_spread":0.2981964606403506,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}